Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PHN.MI
- Price
- 51.00
- Stock movement down
- -0.30 (-0.58%)
- Company name
- Pharmanutra S.p.A
- Exchange
- (MI ,
- Currency
- EUR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 490.00M
- Ent value
- 531.51M
- Price/Sales
- 4.55
- Price/Book
- 8.94
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 33.80
- Forward P/E
- 23.94
- PEG
- -
- EPS growth
- 8.47%
- 1 year return
- -1.54%
- 3 year return
- -7.72%
- 5 year return
- 15.33%
- 10 year return
- -
Last updated: 2025-04-18
DIVIDENDS
PHN.MI does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 33.80 |
| Price to OCF | 24.83 |
| Price to FCF | 33.36 |
| Price to EBITDA | 51.25 |
| EV to EBITDA | 55.59 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 4.55 |
| Price to Book | 8.94 |
| EV to Sales | 4.93 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 9.61M |
| EPS (TTM) | 1.51 |
| FCF per share (TTM) | 1.53 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 107.80M |
| Gross profit (TTM) | 43.66M |
| Operating income (TTM) | 21.97M |
| Net income (TTM) | 14.50M |
| EPS (TTM) | 1.51 |
| EPS (1y forward) | 2.13 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 40.50% |
| Operating margin (TTM) | 20.38% |
| Profit margin (TTM) | 13.45% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 15.54M |
| Net receivables | 25.51M |
| Total current assets | 59.65M |
| Goodwill | 17.56M |
| Intangible assets | 5.68M |
| Property, plant and equipment | 30.71M |
| Total assets | 111.84M |
| Accounts payable | 11.66M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 28.33M |
| Total liabilities | 57.04M |
| Shareholder's equity | 54.81M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 19.74M |
| Capital expenditures (TTM) | 5.05M |
| Free cash flow (TTM) | 14.69M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 26.45% |
| Return on Assets | 12.96% |
| Return on Invested Capital | 19.33% |
| Cash Return on Invested Capital | 19.58% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 51.50 |
| Daily high | 51.50 |
| Daily low | 50.20 |
| Daily Volume | 13K |
| All-time high | 79.00 |
| 1y analyst estimate | 80.30 |
| Beta | 0.34 |
| EPS (TTM) | 1.51 |
| Dividend per share | - |
| Ex-div date | 6 May 2024 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PHN.MI | S&P500 | |
| Current price drop from All-time high | -35.44% | -14.12% |
| Highest price drop | -42.53% | -56.47% |
| Date of highest drop | 9 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -13.98% | -11.07% |
| Avg time to new high | 17 days | 12 days |
| Max time to new high | 837 days | 1805 days |
COMPANY DETAILS
Marketcap
490.00M
Marketcap category
Small-cap
Description
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. It also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. The company's products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Cetilar Tape, Cetilar Oro, Cetilar Nutrition, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. It distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. The company was founded in 2003 and is based in Pisa, Italy.
Employees
112
Website
Investor relations
-
SEC filings
CEO
Country
Italy
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Amidst a challenging economic landscape marked by fresh trade tariffs and fluctuating market sentiment, European markets have experienced some turbulence, with the pan-European STOXX Europe 600 Index ...
April 2, 2025
As the pan-European STOXX Europe 600 Index continues its streak of weekly gains, buoyed by encouraging company results and defense stock rallies, the European market landscape presents intriguing oppo...
March 7, 2025
As global markets navigate a landscape marked by AI competition fears and fluctuating interest rates, small-cap stocks are drawing attention amidst broader market volatility. With indices like the S&P...
February 4, 2025
As global markets navigate a complex landscape marked by fluctuating interest rates and AI competition fears, investors are closely watching for opportunities amidst the volatility. In this environmen...
February 3, 2025
As global markets navigate a holiday-shortened week, characterized by moderate gains and fluctuations in consumer confidence and jobless claims, investors are increasingly focused on growth opportunit...
January 1, 2025
As global markets experience a broad-based rally, with U.S. indexes nearing record highs and smaller-cap stocks outperforming their larger counterparts, investor sentiment is buoyed by strong labor ma...
November 28, 2024
As global markets exhibit broad-based gains, with smaller-cap indexes outperforming their larger counterparts, investors are increasingly looking toward the potential of under-the-radar opportunities....
November 27, 2024
As global markets navigate the challenges of rising U.S. Treasury yields and tepid economic growth, investors are keenly observing how these factors influence stock performance. While large-cap and gr...
October 28, 2024
In the face of recent market volatility and economic slowdown concerns, investors are increasingly seeking stability and growth potential in their portfolios. One key indicator of a promising stock is...
September 11, 2024
This is a new step forward in the steady expansion into foreign markets of PharmaNutra S.p.A. (MTA; Ticker PHN), the company established in 2003 by brothers Andrea and Roberto Lacorte, specializing in...
June 27, 2024